The deal was a massive win for Trillium shareholders; the purchase price of $18.50 per share was triple the stock's closing price just days before the announcement. 2. The Sci-Fi "Story": Jeff Lemire's Trillium
In August 2021, pharmaceutical giant announced its intent to buy Trillium Therapeutics for approximately $2.26 billion .
The request to "buy trillium" can refer to several distinct "stories"—from a massive multi-billion dollar corporate acquisition to a sci-fi epic spanning thousands of years. 1. The Corporate "Story": Pfizer’s $2.3 Billion Bet
Pfizer acquired Trillium to gain access to two lead blood cancer therapies designed to block this signal and help the immune system destroy cancer cells.
If you are looking for a literal story, Trillium is a celebrated eight-issue graphic novel by Jeff Lemire. Story Trillium - UHN Commercialization
